BWAY logo

BrainsWay (BWAY) Company Overview

Profile

Full Name:

BrainsWay Ltd.

Sector:

Healthcare

Country:

Israel

IPO:

April 17, 2019

Indexes:

Not included

Description:

BrainsWay (BWAY) is a medical technology company that develops non-invasive treatments for mental health disorders. They use deep transcranial magnetic stimulation (dTMS) to help patients with depression and other conditions. Their innovative approach aims to improve mental well-being and provide alternatives to traditional therapies.

Key Details

Price

$9.70

Annual Revenue

$31.79 M(+16.96% YoY)

Annual EPS

-$0.26(+67.50% YoY)

PE Ratio

102.86

Beta

0.77

Events Calendar

Earnings

Next earnings date:

Mar 11, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 6, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 23, 24 HC Wainwright & Co.
Buy
Oct 21, 24 HC Wainwright & Co.
Buy
Oct 3, 24 Northland Capital Markets
Outperform
Sep 16, 24 HC Wainwright & Co.
Buy
Aug 8, 24 HC Wainwright & Co.
Buy
Aug 7, 24 Northland Capital Markets
Outperform
Jun 5, 24 HC Wainwright & Co.
Buy
May 9, 24 Oppenheimer
Outperform
May 9, 24 HC Wainwright & Co.
Buy
Mar 11, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for BrainsWay?
  • Does BrainsWay pay dividends?
  • What sector is BrainsWay in?
  • What industry is BrainsWay in?
  • What country is BrainsWay based in?
  • When did BrainsWay go public?
  • Is BrainsWay in the S&P 500?
  • Is BrainsWay in the NASDAQ 100?
  • Is BrainsWay in the Dow Jones?
  • When was BrainsWay's last earnings report?
  • When does BrainsWay report earnings?
  • Should I buy BrainsWay stock now?

What is the ticker symbol for BrainsWay?

The ticker symbol for BrainsWay is NASDAQ:BWAY

Does BrainsWay pay dividends?

No, BrainsWay does not pay dividends

What sector is BrainsWay in?

BrainsWay is in the Healthcare sector

What industry is BrainsWay in?

BrainsWay is in the Medical Devices industry

What country is BrainsWay based in?

BrainsWay is headquartered in Israel

When did BrainsWay go public?

BrainsWay's initial public offering (IPO) was on April 17, 2019

Is BrainsWay in the S&P 500?

No, BrainsWay is not included in the S&P 500 index

Is BrainsWay in the NASDAQ 100?

No, BrainsWay is not included in the NASDAQ 100 index

Is BrainsWay in the Dow Jones?

No, BrainsWay is not included in the Dow Jones index

When was BrainsWay's last earnings report?

BrainsWay's most recent earnings report was on Nov 12, 2024

When does BrainsWay report earnings?

The next expected earnings date for BrainsWay is Mar 11, 2025

Should I buy BrainsWay stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions